Mark Adams, MD
Central Kentucky Research Associate
2
2
2
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
No phase data
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
David Spiegel, MD
Stanford University
Shared therapeutic areas:
Denis E O'Donnell, MD, FRCPC
Queen's University and Kingston General Hospital
Shared therapeutic areas:
Dawson Church, PhD
Soul Medicine Institute
Shared therapeutic areas:
Marie-France Langlois, MD
Université de Sherbrooke
Shared therapeutic areas:
Tai hing Lam, MD
The University of Hong Kong
Shared therapeutic areas:
Sherry A McKee, PhD
Yale University
Shared therapeutic areas:
Nancy A Rigotti, MD
Massachusetts General Hospital
Shared therapeutic areas:
Charlie Strange, MD
Medical University of South Carolina
Shared therapeutic areas:
Garret A FitzGerald, MD
University of Pennsylvania
Shared therapeutic areas:
Dorothy Hatsukami, PhD
University of Minnesota
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
Evaluation of Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2 for 26 Weeks
All 2 trials loaded